Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$1.1M
2 rounds on record
Latest round
$200k
Venture round · Oct 2021 · 4 yr ago
Team
1
US Form 5500 (plan participants) · Dec 2025
Backers
1
Elevate Ventures
The money's age
Long since its last round
59 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 29, 2021 Raised a round Venture round $200k · SEC Form D Dec 31, 2018 Raised a round Venture round $850k · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2021 $200k — SEC Form D
Venture round Dec 2018 $850k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity NERx Biosciences, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Nicholas BallExecutive Officer, DirectorSEC Form D
John TurchiExecutive Officer, DirectorSEC Form D
Katherine PawelczakExecutive Officer, DirectorSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs

People

Nicholas Ball
Executive Officer, Director
John Turchi
Executive Officer, Director
Katherine Pawelczak
Executive Officer, Director
Trent Carrier
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Indianapolis United States
HQ
1-10 est. staff

Financials

Total raised
$1.1M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2021 $200k Details
Venture - Series Unknown 2018 $850k Details